- About Us
- Career Center
- Nano-Social Network
- Nano Consulting
- My Account
October 2nd, 2006
GNI Ltd, a leading biopharmaceutical company in Asia, has announced that its China based affiliate Shanghai Genomics has expanded sales of Gu-Bang(TM), a new type of synthetic bone biomaterial, after winning several hospital supply contracts in Beijing, Shanghai and Guandong province.
Using state-of-art nanotechnology, Gu-Bang(TM) is chemically synthesized to create porous, biodegradable and rigid granules. The material, which is non-toxic, non-irritant and has excellent biocompatibility, does not contain proteins, DNA or endotoxins found in allografts, thus avoiding the risk of abnormal allergic and immunologic reactions following implantation.
|Related News Press|
CAP-XX Launches 0.6mm Thinline Supercapacitors for Designing Wearable, Ultra-Portable and Connected IoT Devices: Eliminated Materials and Changed Processes to Reduce Thickness and Costs to Below $1 May 19th, 2015
Iran Unveils 6 Knowledge-Based Products April 11th, 2015
Researchers develop new way to manufacture nanofibers May 21st, 2015
This Slinky lookalike 'hyperlens' helps us see tiny objects: The photonics advancement could improve early cancer detection, nanoelectronics manufacturing and scientists' ability to observe single molecules May 23rd, 2015
Haydale Named Lead Sponsor for Cambridge Graphene Festival May 22nd, 2015